dihydroguaiaretic acid has been researched along with Experimental Mammary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MS; Choi, Y; Jeon, S; Jeong, HJ; Kang, TH; Oh, ST; Shin, HM | 1 |
1 other study(ies) available for dihydroguaiaretic acid and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Meso-dihydroguaiaretic acid induces apoptosis and inhibits cell migration via p38 activation and EGFR/Src/intergrin β3 downregulation in breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; ErbB Receptors; Female; Genes, src; Guaiacol; Humans; Integrin beta3; Lignans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; p38 Mitogen-Activated Protein Kinases | 2015 |